Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03138083
Title OMO-1 in Solid Malignancies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Octimet Oncology N.V.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | GBR | FRA | BEL


No variant requirements are available.